Jaguar Health, Inc. (JAGX) Total liabilities 2016–2025
Jaguar Health, Inc. (JAGX) total liabilities at each fiscal year-end, per SEC filings.
$57.0MFY2025 · since FY2016: $6.0M → $57.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $57.0M | +28.3% |
| FY2024 | $44.4M | -3.1% |
| FY2023 | $45.9M | -6.0% |
| FY2022 | $48.8M | +17.9% |
| FY2021 | $41.4M | +61.5% |
| FY2020 | $25.6M | +61.9% |
| FY2019 | $15.8M | -40.6% |
| FY2018 | $26.7M | +1.1% |
| FY2017 | $26.4M | +338.2% |
| FY2016 | $6.0M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More JAGX financial trends
JAGX RevenueJAGX Net incomeJAGX Net marginJAGX Gross profitJAGX Gross marginJAGX Operating incomeJAGX Operating marginJAGX Operating cash flowJAGX Free cash flowJAGX Capital expendituresJAGX Return on equityJAGX Stock buybacksJAGX Dividends paidJAGX Total assetsJAGX Shareholders’ equityJAGX overview →